Public Trust in Experts: It’s on Us to Be the Solution | Andrew Coop, PhD, MA | School of Pharmacy
How do researchers and scholars build public trust? It's all about integrity and benevolence.Andrew Coop, PhD, MA, professor in the Department of Pharmaceutical Sciences and associate dean for Graduate Programs in the University of Maryland School of Pharmacy, shared those words during the third annual Faculty Convocation at the University of Maryland, Baltimore.Dr. Coop has been a faculty member at the University of Maryland School of Pharmacy since 1999, serving as chair of the Department of Pharmaceutical Sciences (PSC) from 2007 to 2015. In addition to his current role as UMSOP’s associate dean for graduate programs, he previously served as the school’s associate dean for academic affairs from 2016 to 2024 and as PSC’s vice chair of academic affairs from 2006 to 2007. Coop has received funding from the National Institutes of Health’s National Institute on Drug Abuse for his research on opioids, stimulants, and depressants, all of which were interdisciplinary projects concerned with the design and development of novel tools to allow pharmacological study of the biological systems involved in the abuse of these drugs
More from Youtube
- 0:40UMB Founders Week Staff Lunch 2025UMB President Bruce Jarrell, UMB deans, administrators, and vice presidents served lunch in appreciation of our dedicated staff during this annual Founders Week tradition.
- 0:42UMB Student Cookout | Founders Week 2025University of Maryland, Baltimore had the opportunity to get a free lunch from President Bruce E. Jarrell, MD, FACS, deans and vice presidents in this annual Founders Week tradition.
- 2:55Fighting Life-Threatening Sepsis with Nanoparticles | Breakthroughs Can't WaitRyan Pearson, PhD, associate professor of pharmaceutical sciences and director of the Bio- and Nano-Technology Center at the University of Maryland School of Pharmacy has been awarded a $3.4 million grant from the National Institutes of Health to move forward with a unique approach to defeating sepsis using nanoparticles. His approach is different because the custom-designed nanoparticles are not used to transport other drugs, but are themselves the treatment.
- 2:10Can a proven cancer drug be reimagined to fight brain tumors in kids? | Breakthroughs Can't WaitAs an ACS-IMPACT Research Scholar at the University of Maryland, Baltimore, Gabrielle Olibris spent her summer in the lab of Aditi Banerjee, PhD, targeting medulloblastoma, a pediatric brain cancer, with a novel therapeutic compound called BNPP-433.3 Beta.BNPP-433.3 Beta shows strong potential, she said, explaining, “This is already patented, so it’s a drug that’s already being used to treat prostate cancer.”By exploring a new use for an existing cancer drug, Olibris hopes to help advance research that could lead to safer, more effective treatments for children.#breakthroughscantwaitumb #cancerresearch
- 2:28Student of the Year Danielle D. Basdekis | Founders Week 2025With a passion for social justice and public interest law, Danielle Basdekis arrived at the University of Maryland Francis King Carey School of Law in 2023 to pursue a Juris Doctor degree and hit the ground running. In two years, she has distinguished herself as a student, scholar, and leader, with her contributions significantly enriching the law school and advancing the mission of the University of Maryland, Baltimore (UMB).The third-year student has made her mark on the Francis King Carey School of Law through her academic pursuits and leadership roles. Basdekis, who will be a clerk for Justice Angela Eaves on the Supreme Court of Maryland after graduating next spring, said she was “overwhelmed” by the Student of the Year honor.Read more: https://elm.umaryland.edu/elm-stories/2025/Founders-Week-2025-Student-of-the-Year-Danielle-D-Basdekis.php
- 2:44David J. Ramsay Entrepreneur of the Year Rajabrata Sarkar, MD, PhD | Founders Week 2025Being named the University of Maryland, Baltimore (UMB) 2025 Founders Week David J. Ramsay Entrepreneur of the Year has been a full-circle moment for Rajabrata Sarkar, MD, PhD.The School of Medicine professor is an expert in treating blood vessel disorders, a nationally known researcher in his field, and a partner in the medical technology startup MDC Studio.Read more: https://elm.umaryland.edu/elm-stories/2025/Founders-Week-2025-David-J-Ramsay-Entrepreneur-of-the-Year-Rajabrata-Sarkar-MD-PhD.php
